| Protection against cis-diamminedichloroplatinum-induced nephrotoxicity by 2,3-dimercaptosuccinic acid in rats. | |
| | |
MedLine Citation:
|
PMID: 10586422 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The present study was designed to examine the usefulness of 2,3-dimercaptosuccinic acid (DMSA) for the purpose of reducing cis-diamminedichloroplatinum (DDP)-induced nephrotoxicity and effective clinical use of DDP and safe. The effectiveness of DMSA on the DDP-excretion in rat kidney was observed by measuring the platinum concentration using Atomic Absorption Instrument. Co-administration of DMSA (1.0 or 2.0 mmol/kg) 1 hour after DDP injection (20 mumol/kg) showed more decrease in the platinum concentration than that immediately after DDP injection. The alleviating effect of DMSA on DDP toxicity was evaluated by lipid peroxidation, enzymatic antioxidants, and glutathione levels. The administration of DDP alone caused a significant increase in lipid peroxidation and significant decreases in enzymatic antioxidants and glutathione levels in the kidney. Co-administration of DMSA (2.0 mmol/kg) 1 hour after DDP injection showed the most effective reduction of these enzymatic damages caused by DDP. These findings suggested that the co-administration of DMSA (2.0 mmol/kg) 1 hour after DDP injection leads DDP to effective excrete from renal tissue and suppresses the lipid peroxide reaction and results in reduction of nephrotoxicity. |
| | |
Authors:
|
K Mishima; S Hidaka; N Takamura; S Shinozawa |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Renal failure Volume: 21 ISSN: 0886-022X ISO Abbreviation: Ren Fail Publication Date: 1999 Nov |
Date Detail:
|
Created Date: 1999-12-21 Completed Date: 1999-12-21 Revised Date: 2008-05-21 |
Medline Journal Info:
|
Nlm Unique ID: 8701128 Medline TA: Ren Fail Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 593-602 Citation Subset: IM |
Affiliation:
|
Department of Pharmacy, Miyazaki Medical College Hospital, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antioxidants / metabolism Chelating Agents / pharmacology* Cisplatin / pharmacokinetics, toxicity* Glutathione / metabolism Kidney / drug effects*, metabolism Lipid Peroxidation / drug effects Male Rats Rats, Wistar Succimer / pharmacology* |
| Chemical | |
Reg. No./Substance:
|
0/Antioxidants; 0/Chelating Agents; 15663-27-1/Cisplatin; 304-55-2/Succimer; 70-18-8/Glutathione |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antioxidants in the prevention of renal disease.
Next Document: Importance of early and continuous use of protein restriction on the progression of adriamycin nephr...